Skip to main content
. 2014 Nov 17;7:2111–2120. doi: 10.2147/OTT.S71646

Figure 8.

Figure 8

Disease-free survival estimates for patients with response to neoadjuvant chemotherapy, resulting in comparison of ypT1–T2 stage patients with ypT3–T4 stage patients.